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Rethinking Rehabilitation
A REVIEW OF PATIENT POPULATIONS WHO CAN BENEFIT FROM CARDIAC
REHABILITATION
Brittany Overstreet, PhD; Danielle Kirkman, PhD; Wanda Koester Qualters, MS; Dennis Kerrigan, PhD;
Mark J. Haykowsky, PhD; Marysia S. Tweet, MD; Jeffrey W. Christle, PhD; Clinton A. Brawner, PhD;
Jonathan K. Ehrman, PhD; Steven J. Keteyian, PhD

 lthough cardiac rehabilitation (CR) is safe and highly effective
A
for individuals with various cardiovascular health conditions, to
date there are only seven diagnoses or procedures identified by
the Centers for Medicare & Medicaid Services that qualify for
referral. When considering the growing number of individuals
with cardiovascular disease (CVD), or other health conditions
that increase the risk for CVD, it is important to determine the
extent for which CR could benefit these populations. Furthermore, there are some patients who may currently be eligible for
CR (spontaneous coronary artery dissection, left ventricular
assistant device) but make up a relatively small proportion of
the populations that are regularly attending and participating.
Thus, these patient populations and special considerations for
exercise might be less familiar to professionals who are supervising their programs. The purpose of this review is to summarize
the current literature surrounding exercise testing and programming among four specific patient populations that either do not
currently qualify for (chronic and end-stage renal disease, breast
cancer survivor) or who are eligible but less commonly seen in
CR (sudden coronary artery dissection, left ventricular assist device). While current evidence suggests that individuals with these
health conditions can safely participate in and may benefit from
supervised exercise programming, there is an immediate need
for high-quality, multisite clinical trials to develop more specific exercise recommendations and support the inclusion of these
populations in future CR programs.
Key Words: cardiac rehabilitation • exercise • special populations

C

ardiac rehabilitation (CR) is a class 1 guideline-based
therapy that provides comprehensive secondary prevention strategies. Best practices for CR include exercise
training, outcome assessments, risk factor management,
and nutritional/behavioral education to individuals who
qualify. Research indicates that CR participation provides many health benefits including reduced risk for morbidity and mortality, increased cardiorespiratory fitness
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(CRF), enhanced quality of life, and improved mood and
symptoms.1,2 Furthermore, CR is cost-effective by reducing the rate of recurrent myocardial infarctions (MIs) and
hospital readmissions.3 Several meta-analyses have demonstrated the benefits of CR programs, specifically examining the individual components of these programs and their
impact on patient well-being.4,5 Despite the large number
of different cardiovascular diseases (CVD), only seven diagnoses or procedures qualify an individual for CR (Table 1).
While this list may seem robust to some, it is only a fraction of the chronic health conditions that physical activity
and lifestyle interventions (ie, education, counseling, and
social support) have been shown to benefit. Specifically,
exercise is beneficial for individuals with conditions that
are strongly associated with CVD including chronic kidney
disease (CKD)6-11 and breast cancer (BC).12-15 Given the
observed associations between these diseases and CVD, it
seems appropriate to consider the inclusion of these individuals in CR as a strategy to help manage their CVD risk.
Additionally, some patients who attend CR present with
cardiovascular comorbid conditions (eg, spontaneous coronary artery dissection, [SCAD]; left ventricular assist device, [LVAD]), not easily identified in Table 1. Often, these
individuals will make up a relatively small proportion of the
populations that traditionally participate in CR and thus
professionals may be less familiar with the current guidelines for patient-centered care.
The purpose of this review is to present relevant information for the CR practitioner about patient populations that
either do not currently qualify for (ie, chronic and end-stage
CKD, BC survivor) or who are eligible but less commonly
cared for in CR (ie, SCAD and LVAD). We also address special CR-related considerations and expected outcomes to
better inform clinicians and researchers. Additionally, randomized control trials and clinical trials from the past decade, which support the benefits of exercise programming
for CKD, SCAD and LVAD patient populations, have been
summarized in Tables 2, 3, and 4. While not a systematic review, our tables provide important references for CR
professionals to better understand the potential benefits of
exercise for these populations. A summary for BC survivors
was not provided, as a recent systematic review by Furmaniak et al16 provides the information CR professionals
would find beneficial regarding this population.

REVIEW OF RELEVANT LITERATURE
CHRONIC AND END-STAGE KIDNEY DISEASE
Chronic kidney diseases represent a major public health
problem, affecting at least one in seven adults in the United States.17 The disease progresses through five stages,
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Table 1
Medical Conditions Eligible for Cardiac Rehabilitation
Approved by the Centers for Medicare & Medicaid Services
Eligibility Criteria

a

Class of Indication

Myocardial infarction within the last 12 mo

Class 1a indication

Coronary artery bypass graft surgery

Class 1 indication

Current stable angina

Class 1 indication

Heart valve repair or replacement

Class 1 indication

Percutaneous coronary angioplasty or coronary stent

Class 1 indication

Heart or heart-lung transplant

Class 1 indication

Stable chronic heart failure with New York Heart
Association class II-IV and left ventricular ejection
fraction ≤35%

Class 2ab indication

Strong recommendation.
Moderate recommendation.

b

classified according to the estimated glomerular filtration
rate, with the fifth stage requiring some form of renal replacement therapy (eg, dialysis or a kidney transplant).
Patients with CKD experience a substantial CVD burden,
the etiology of which is not fully explained by traditional
risk factors.17 Despite advancements in the development of
pharmaceutical agents targeting hypertension and diabetes,
patients with CKD are more likely to die from CVD than
progress to end-stage renal disease (ESRD).17 Furthermore,
statin therapies are ineffective at improving outcomes in
the ESRD population.18 As a result, there is a critical unmet clinical need to develop and implement strategies to
improve cardiovascular health in this patient population.
Targeted interventions, such as CR, that address the prevention and management of CVD progression, would be
notably beneficial in the earlier stages of the disease. In this
respect, clinical guidelines specify the management of CVD
progression as a treatment for CKD as early as stages one
and two.19
There is a wealth of evidence documenting a myriad of
health benefits of exercise training across the spectrum of
kidney diseases (Table 2).9,20-28 Regular exercise on most, if
not all days of the week, is currently recommended by the
Kidney Disease Quality Initiative clinical guidelines.19 Despite the current evidence and clinical guidelines, exercise
is still not integrated as part of standard of care treatment
in nephrology. One consistently cited barrier to implementing exercise in this patient population is a lack of time and
information among nephrology health care providers to effectively counsel and prescribe exercise.6 Therefore, referral
to CR represents an attractive strategy to facilitate the integration of exercise for CVD prevention and management
in these patients.
Exercise Testing
Exercise testing prior to enrollment in CR can provide clinicians valuable information regarding underlying disease,
contraindications to starting exercise, and current CRF. Protocols including a 6-min walk test (6MWT), intermittent
shuttle walk test, and timed get up and go assessment are
commonly used to assess functional fitness in this population.
These tests are typically easy to administer and relatively safe
for higher risk populations. While these assessments provide
information such as heart rate (HR) and blood pressure (BP)
responses, which are very useful for exercise programming,
cardiopulmonary exercise tests (CPX) can provide other values useful to the CR team. Prior studies involving CPX reveal

lower CRF levels (peak oxygen uptake [V̇o2peak] = 17.4 vs 28
mL/kg/min), ventilatory-perfusion mismatch (V̇E/V̇co2 slope
32 vs 28 and PetCO2: 27 vs 31 mm Hg), as well as blunted maximal HR (134 vs 159 bpm) and 1-min HR recovery
responses in patients with CKD compared with healthy controls (15 vs 20 bpm, respectively).7 In this respect, CPX is a
useful tool for identifying subclinical cardiovascular abnormalities in this population.
Exercise Prescription and Training
Regular exercise training improves CRF, muscular strength,
and quality of life in patients with CKD.8 In nondialysis
CKD, moderate- to vigorous-intensity aerobic exercise
improves endothelial and microvascular function, both of
which are precursors to the development of atherosclerosis.9 Additionally, in these patients regular aerobic exercise
reduces chronic inflammation, a consistently cited nontraditional risk factor of CVD that is a hallmark of CKD.10 Given
the independent association between muscular strength and
CVD,29 improvements in muscular strength that accompany exercise training in these patients8 may also be beneficial in mitigating cardiometabolic risk. As CKD progresses
to require renal replacement therapy, exercise training is a
powerful tool for improving CRF and counteracting muscle
wasting and frailty while also improving prognosis once a
patient initiates dialysis or receives a kidney transplant.11
For individuals who receive a kidney transplant, exercise
training may be helpful to counteract the cardiometabolic
risk factors associated with immunosuppression medication
therapy.30 Once a patient initiates dialysis, it may be more
difficult to enroll them in CR on their dialysis day due to the
time burden of their dialysis treatments. For these patients,
exercising during hemodialysis (intradialytic exercise) may
be an alternative strategy that has proven benefits for improving physical function, lessening hemodialysis-related
myocardial stunning, sarcopenia, dialysis adequacy, and dialysis-related symptoms.31-33 While it is understood that exercise training in these patients during hemodialysis would
not be practical within the traditional CR class setting, CR
staff do have the ideal clinical skill set to supervise such
training and provide surveillance.
Current recommendations are to implement aerobic, resistance, balance, and flexibility exercises according to current guidelines for older adults and to take into account
special considerations for any comorbidities that the patient
may present with.34,35 A summary of the current exercise
recommendations from the American College of Sports
Medicine35 can be found in Table 5. Lastly, patients should
avoid exercise if acute infection, hyperkalemia, excess intradialytic weight gain, or peripheral or pulmonary edema
is present.35
BREAST CANCER SURVIVORS
Breast cancer is the most commonly diagnosed malignancy and the leading cause of cancer mortality among female
patients worldwide.36 In the United States, female BC mortality has decreased by 41% since 1989 due to advances
in prevention, early detection, and adjuvant therapy.37 A
consequence of improved survival and population aging is
that BC survivors face an important new set of health challenges. Specifically, CVD is a leading cause of death in older
BC survivors.38 The increased CVD risk has been attributed
to unfavorable lifestyle factors (eg, sedentary lifestyle and
obesity) combined with the adverse effects of anticancer
therapy.39,40 Accordingly, an important goal is to improve
overall health and CRF across the continuum of BC survivorship.41 A recent scientific statement from the American
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Table 2
Key Randomized Controlled Trials Investigating the Effects of Exercise on Cardiovascular Disease-Related Outcomes in CKD
Author

Groups

Exercise Intervention

CV Outcome Measures

Findings

Mustata et al
(2011)20

Exercise (n = 10)
Control (n = 10)

F: 5x/wk (60 min)
I: 40-60% V̇o2peak
T: Aerobic
T: 52 wk

Arterial compliance
CRF

No change in pulse wave augmentation index
Increase in V̇o2peak with ExT

Headley et al
(2012)21

Exercise (n = 10)
Control (n = 11)

F: 3x/wk (45 min)
I: 50-60% V̇o2peak
T: Aerobic and
resistance
T: 48 wk

Ambulatory BP
Autonomic function
Blood lipids
Inflammatory biomarkers
Vascular biomarkers
CRF

No change in 24-hr BP
Increase in 1-min exercise heart rate recovery with ExT
Decrease in total cholesterol and LDL-C in control group
No change in IL-6 or hs-CRP
No change in ADMA
Increase in V̇o2peak with ExT

Howden et al
(2013)22

Exercise (n = 36)
Control (n = 36)

F: 2x/wk (75 min)
I: 11-13 RPE
T: Aerobic
T: 18 wk

Central BP
Blood lipids
Ventricular-vascular
interaction
Arterial compliance
Cardiac function
CRF

No change in central BP
No change in blood lipids
Improvement in arterial elastance with ExT
No change in pulse wave velocity or pulse wave augmentation
index
Improvement in left ventricular systolic and diastolic function
Increase in V̇o2peak with ExT

Headley et al
(2014)23

Exercise (n = 25)
Control (n = 21)

F: 3x/wk (55 min)
I: 50-60% V̇o2peak
T: Aerobic
T: 16 wk

BP
Arterial compliance
Inflammatory biomarkers
Vascular biomarkers
Body composition
CRF

No change in BP
No change in pulse wave velocity
No change in hs-CRP
Decrease in circulating Endothelin-1 with ExT
No change in % fat mass
Increase in V̇o2peak with ExT

Greenwood et al
(2015)24

Exercise (n = 8)
Control (n = 10)

F: 3x/wk (40 min)
I: 80% HRR
T: Aerobic and
resistance
T: 52 wk

BP
Blood lipids
Arterial stiffness
Inflammatory biomarkers
Body composition
CRF

No change in BP
No change in blood lipids
Decrease in pulse wave velocity with ExT
No change in hs-CRP
Decrease in waist circumference with ExT
Increase in V̇o2peak with ExT

Van
Craenenbroeck
et al (2015)25

Exercise (n = 19)
Control (n = 21)

F: 4x/wk (10 min)
I: 90% AT
T: Aerobic
T: 12 wk

BP
Blood lipids
Vascular endothelial function
Arterial compliance
Vascular biomarkers
Inflammatory biomarkers
CRF

No change in BP
Decrease in total cholesterol in control group
No change in flow-mediated dilation
No change in pulse wave velocity or pulse wave augmentation index
No change in endothelial progenitor cell proliferation or
circulating cell migratory capacity
No change in hs-CRP
Increase in V̇o2peak with ExT

Headley et al
(2017)26

Exercise (n = 25)
Control (n = 21)

F: 3x/wk (55 min)
I: 50-60% V̇o2peak
T: Aerobic
T: 16 wk

Ambulatory BP
Post-exercise hypotension

No change in daytime or nighttime BP
No change in post-exercise hypotension

Kirkman et al
(2019)9

Exercise (n = 15)
Control (n = 16)

F: 3x/wk (45 min)
I: 60-85% HRR
T: Aerobic
T: 12 wk

Central BP
Microvascular function
Vascular endothelial function
Arterial compliance
Arterial hemodynamics
Oxidative stress biomarkers
CRF

No change in central BP
Improvement in microvascular conductance with ExT
Flow-mediated dilation preserved with ExT
No change in pulse wave velocity or pulse wave augmentation index
No change in forward or reflect traveling waveform amplitudes
No change in urinary F2-isoprostanes
Increase in V̇o2peak with ExT

Huppertz et al
(2020)28

Exercise (n = 81)
Control (n = 80)

F: 2x/wk (75 min)
I: 11-13 RPE
T: Aerobic
T: 18 wk

Autonomic function
CRF

No change in heart rate variability and 1-min exercise heart rate
recovery
Increase in V̇o2peak with ExT

Exercise (n = 14)
Control (n = 12)

F: 3x/wk (45 min)
I: 60-85% HRR
T: Aerobic
T: 12 wk

Autonomic function
Cardiac function
Ventilation-perfusion matching
CRF

No change in autonomic function
Improvement in indexed O2pulse with ExT
No change in V̇E/V̇co2 and V̇  E/V̇o2 slopes
Increase in V̇o2peak with ExT

Kirkman et al
(2020)27

Abbreviations: ADMA, asymmetric dimethylarginine; AT; BP, blood pressure; CKD, chronic kidney disease; CRF, cardiorespiratory fitness; ExT, exercise training; F, frequency of exercise; GSH,
glutathione; HRR, heart rate reserve; hs-CRP, high-sensitivity C-reactive protein; I, intensity of exercise; IL-6, interleukin-6; LDL-C, low-density lipoprotein cholesterol; LPO, lipid peroxidation
product; RPE, rating of perceived exertion: T, type of exercise; T, time of exercise training intervention.
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9 women, 0 men
(average age
47 yr)

70 women, 0
men (average
age 52 yr)

1 female (age
39 yr)

1 male (age
22 yr)

1 female (age
53 yr)

Silber et al
(2015)54

Chou et al
(2016)61

Patterson et al
(2016)53

Weber et al
(2018)55

Brown et al
(2019)60

Final CR session: peak transient change in BP over
time (dP/dt) was continuously recorded during RT
and core exercise as well as during cough, forced
Valsalva, and provoked sneeze

CPX post-exercise intervention only

Submax CPX 1 mo post-event. Submax ETT (no
CPX) at 3 and 6 mo post-event

Pre and post-ETT

Pre and post-CPX or 6MWT

6MWT

Exercise Assessment

5-min WU before 20-30 min jogging or stepper.
Two sets of 10 (moderate intensity) of 1 RT
activity and 2 sets of 1 core activity for 30
sec.

WU and CD. Initial 23 sessions: low-/moderateintensity TM, bike and RT; then 32 sessions
over 11 mo with simulated competitive
cycling.

Initial 2 mo: CV exercise ≤30 min, longer WU
than usual, RPE 3-5 (on 1-10), HR <140
bpm, avoided jogging. RT: 3-7 d, light effort.
At mo 3: HR <150 bpm up to 1 hr, added
interval jogging. RT moderate effort. At mo
6: no limit to duration, HR <165 bpm, 6-7
on RPE 1-10, avoided training for marathon
distances. RT: up to moderate/vigorous effort,
avoiding Valsalva.

1 hr, 1x/wk (15-min WU, 30 min-CV exercise,
15-min CD). RT with 2-12 lb. THRR 50-70%
of HRR. SBP <130 mm Hg. Advised not to
lift >20 lb.

1-3x/wk (5-min WU, 30- to 45-min CV exercise,
5-min CD). RT/core 10-20 min. THRR 6070% HRR and/or RPE 12-14. HIIT performed
once able to complete 20-min MICT (1-2 min
at RPE 15-17 interspersed with moderateintensity intervals of RPE 12-14).

3x/wk, 1 hr (20-min WU, 15-min TM, 15-min
bike, 4-min supine recovery)

Exercise Intervention

18

55 over 3 yr

NA

12.4 ±
10.5 wk

28 (5-39)
visits

21

Sessions
Attended

Cough, Valsalva and sneeze were
shown to have the greatest dP/
dt over RT and core exercise.

Achieved 14 METs

Max ETT at 6 mo post-event: 13
METs

10 METs at program initiation ±
3 METs; at exit 11.5 ±3.5
At entry, 63% had recurrent CP,
at exit 37%

CPX: peak oxygen uptake
increased by 18% (4.4 mL/
kg/min, average). 6MWT
increased 22%.

445-m pre-, 540-m postexercise intervention (21%
improvement)

Outcomes

Enrolled 1 yr post-event to
specifically perform RT and
core activities

Time to enrollment not reported.
Training was symptom limited
(no limits on HR, BP, RPP, RPE).

ET initiated 1 mo post-event. At
8 mo post-event, patient was
running 3-5 mi 3x/wk, elliptical
30-45 min and/or spin cycle
for 45 min 1x/wk.

Enrollment median 0.6 yr after
event. Supervised exercise in
open gym available in addition
to 1x/wk session. 20-min
education/wk on nutrition, risk
factors, stress management;
counseling and peer support
available.

CR initiated 1-2 wk post-MI.
Education and counseling
regarding nutrition,
weight control and stress
management

Time to enrollment not reported

Notes

Abbreviations: BP, blood pressure; CD, cool down; CP, chest pain; CPX, cardiopulmonary exercise test; CR, cardiac rehabilitation; CV, cardiovascular; dP/dt, derivative of pressure over time; ET, exercise training; ETT, exercise treadmill test; HIIT, high-intensity interval training;
HR, heart rate; HRR, heart rate reserve; MET, metabolic equivalent of task; MI, myocardial infarction; MICT, moderate-intensity continuous training; NA, not applicable; RPE, rating of perceived exertion; RPP, rate pressure product; RT, resistance training; SBP, systolic blood
pressure; THRR, target heart rate range; TM, treadmill; WU, warm up; 6MWT, 6-min walk test.

1 female (age
36 yr)

Patients

de Carvalho Pinto
et al (2014)56

Study

Table 3
Exercise Intervention in Those With Spontaneous Coronary Artery Dissection
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51 (29-71)

55 ± 12

55 ± 13

46 ± 14

47 ± 15

38 ± 16

Age, yr

HeartMate II
HeartMate III

HeartMate II
HeartWare

HeartMate II
HeartWare

EXCOR HeartWare

VentrAssist

First-generation
pulsatile and
second-generation
continuous flow

Device Type

Exercise Intervention

V̇o2peak, KCCQ,
and LV
echocardiogram
measures

V̇o2peak, resistance
training
workloads

V̇o2peak, 6MWT,
isokinetic leg
strength, KCCQ

V̇o2peak, Beck
Depression
Scale, SF-36

V̇o2peak, 6MWT,
SF-36

Average
Sessions
Attended

Median 13 out of
15 sessions

32 ± 6
sessions. No
predetermined
total expected

17.8 ± 3.2 out
of 18 sessions

Within group improvements Not reported
in V̇o2peak, V̇E/V̇co2 slope,
6MWD, inspiratory
muscle endurance, and
MLWHFQ for the training
group
Both groups showed
21.3 ± 1.5 out
improvements in V̇o2, and
of 24 sessions
6MWD. No significant
difference between
groups. Some domains
of the SF-36 improved in
the training group
Within group improvements Not reported
in V̇o2peak, symptoms of
depression, and some
domains of the SF-36

Outcomes

Within group improvements
in V̇o2peak, V̇o2 at VT,
and 6MWD for the
training group. Within
and between group
improvements for
treadmill time, KCCQ, and
isokinetic leg strength
Within group improvements
∼32 CR sessions using a
in V̇o2peak and leg
combination of stationary cycling
strength based upon
and free walking at an RPE of 13
increased training
on the Borg scale. Lower extremity
workload
strength training 2 sets, 12 reps
5-wk training period, 3 d/wk−1 of
Within group improvements
high-intensity exercise training on
in V̇o2 at VT and LV enda cycle ergometer. HIIT protocol:
diastolic volume
30-sec warm-ups. Six 30-sec
high-intensity intervals followed by
4-min active recovery.

8-wk training period. 90 min, 3 d/wk
using various aerobic modalities
and 8 upper and lower body
resistance exercises. Aerobic
exercise was at 60-70% V̇o2peak
6-wk training period 30 min, 3 d/wk
of combined stationary cycling,
treadmill, or recumbent stepper.
Intensity was set at 60% or heart
rate reserve or an RPE of 11-14
on the Borg scale.

8-wk training period. 60 min, 3 d/wk
using combined stationary cycling,
treadmill, and 6 strength training
exercises. Cycling intensity was
50% of heart rate reserve or an
RPE of >13 on the Borg scale.

V̇o2peak, 6MWT, PFT, 10-wk training period. 45 min, on
MLWHFQ
a bike or treadmill at an RPE of
12-14 on the Borg scale.

Exercise Testing
and QOL Metrics

One subject had recurrent
asymptomatic
supraventricular
tachycardia that occurred
after the planned increase
in workloads during the
fourth training session

One patient experienced an
episode of nonsustained
ventricular tachycardia

One patient had a syncopal
event associated with
nonsustained ventricular
tachycardia immediately
after exercise

None reported

None reported

None reported

Signs, Symptoms and/or
Adverse Events

Notes

Prospective, observational
study. Supervised
training was conducted
individually with a
physician. Median time
of LVAD support prior
to training was 18 mo
(range 3-64 mo).

Retrospective analysis.
Training was
conducted within CR
classes

Retrospective study
comparing patients
with heart failure, to
transplant, to LVAD
who participated in CR.
Randomized control
design. Training was
conducted within CR
classes

Randomized control
design. First
randomized exercise
trial in patients with
LVADs

Randomized control
design. Combined
home and supervised
exercise.

Abbreviations: CR, cardiac rehabilitation; HIIT, high-intensity interval training; KCCQ, Kansas City Cardiomyopathy Questionnaire; LV, left ventricular; LVAD, left ventricular assist device; MLWHFQ, Minnesota Living With Heart Failure Questionnaire; PFT, pulmonary function test;
QOL, quality of life; RPE, rating of perceived exertion; SF-36, Short-form 36-item Health Survey Questionnaire; THRR, target heart rate range; TM, treadmill; VT, ventilatory threshold; V̇o2peak, peak oxygen uptake; WU, warm up; 6MWT, 6-min walk test.

5, 10

7, 19

Kerrigan et al
(2014)69

Villela et al
(2021)73

2, 9

Karapolat et al
(2013)68

8, 33

2, 10

Hayes et al
(2012)71

Marko et al
(2015)72

1, 14

Laoutaris et al
(2011)70

Study

Patients
(Female,
Male), n

Table 4
Exercise Intervention in Those With Left Ventricular Assist Devices

Table 5
American College of Sports Medicine's Exercise Recommendations for Chronic Kidney Disease and Cancer Survivorsa
Aerobic Exercise

Resistance Exercise

Flexibility Exercise

CKD
Frequency

3-5 d·wk−1

2-3 d·wk−1

2-3 d·wk−1

Intensity

Moderate intensity (40-59% V̇o2R, RPE 65-75% estimated 1-RM.
12-13 on a scale of 6-20)
Performance 1-RM is not
recommended unless medically
cleared for such effort; instead,
estimate 1-RM from a ≥3-RM test.

Static: Stretch to the point of tightness
or slight discomfort. PNF: 20-75%
maximum voluntary contraction.

Duration

20-60 min·d−1 of continuous
activity; however, if this cannot be
tolerated, use 3- to 5-min bouts
of intermittent exercise aiming to
accumulate 20-60 min·d−1.

A minimum of 1 set of 10-15
repetitions, with a goal in most
individuals to achieve multiple sets.
Choose 8-10 different exercises
targeting the major muscle groups.

60 sec/joint for static (10- to 30-sec
hold/stretch); 3- to 6-sec
contraction followed by 10- to
30-sec assisted stretch for PNF.

Modality

Prolonged, rhythmic activities using
large muscle groups (eg, walking,
cycling, and swimming)

Machines, free weights, bands, body
weight

Static or PNF

Frequency

3-5 d·wk−1

2-3 d·wk−1 with a minimum of 48 h/
sessions

2-3 d·wk−1 up to daily

Intensity

40 to <60% V̇o2R or HRR. Survivors
may find RPE useful to gauge
exercise intensity.

60-80% 1-RM or allow for 6-15
repetitions. Increase weight as
tolerated and when repetitions
>15. RPE is correlated with %
1-RM in cancer survivors.

Stretch within limits of pain to the point
of tightness or slight discomfort.

Duration

≥30 min·d−1. No lower limit on bout
length. During treatment, exercise
length may need to be modified
due to chemotherapy or radiationrelated toxicities.

≥1 set, ≥8 repetitions/set; ≥60-sec
rest between sets

Static: 10-30 sec/stretch

Modality

Walking, cycling, swimming.
Swimming should not be prescribed
for survivors with central lines,
those with ostomies, those in an
immunocompromised state or who
are currently receiving radiation
therapy.

8-10 exercises of major muscle
groups, machines, or free weights

Static stretches (passive and/or active),
for all major tendon groups. Tai chi
and yoga may be preferred.

Cancer survivors

Abbreviations: BC, breast cancer; CKD, chronic kidney disease; HRR, heart rate reserve; PNF, proprioceptive neuromuscular facilitation; RPE, rating of perceived exertion; V̇o2R, oxygen uptake
reserve; 1-RM, 1-repetition maximum, 3-RM, 3-repetition maximum.
a
These tables have been re-created, with permission, from the 11th edition of the American College of Sports Medicine's Guidelines for Exercise Testing and Prescription.35

Heart Association by Gilchrist et al42 provides an excellent
example of a multimodal model like CR for cancer patients
and survivors (ie, cardio-oncology rehabilitation) and emphasizes the need for research to determine the full impact
that such services could have on the overall health of BC
survivors. Furthermore, Dolan et al43 observed improvements to physical (CRF, functional assessments) and mental
(depression, quality of life) outcomes when implementing
personalized exercise programs based on the CR model in
BC survivors. Below is a summary of the current literature
that supports the benefits of exercise testing and programming for this patient population.
Exercise Testing
While exercise testing is not required for BC survivors
to begin an exercise program, reduced oxygen uptake at
peak exercise is commonly observed in this population.
Jones et al44 reported that BC survivors (n = 248, mean
age: 55 yr, mean left ventricular ejection fraction: 62%)

have a V̇o2peak that is 27% lower than age-matched healthy
sedentary female populations. Also, 32% of BC survivors
had a V̇o2peak below the threshold level required for functional independence.44 Exercise testing may be beneficial in
identifying initial CRF levels as well as the mechanisms underpinning their reduced CRF. In accordance with the Fick
principle, the reduced V̇o2peak may be the result of cardiac
and “noncardiac” peripheral factors that result in decreased
convective and diffusive oxygen transport and reduced oxygen utilization by the exercising muscles.12,41 Specifically,
evidence to date suggests that the lower V̇o2peak is due to a
lower peak exercise cardiac output39,45 secondary to a lower peak exercise stroke volume39,45 and end-diastolic volume index,45 as peak exercise HR39,45 and arterial-venous
oxygen difference39 are not significantly different between
BC survivors and controls. The finding of normal oxygen
extraction despite a lower cardiac output suggests that peripheral vascular and/or skeletal muscle abnormalities that
result in decreased muscle oxygen diffusive conductance
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may also limit V̇o2peak in BC survivors.12 Indeed, Beaudry
et al46 found that BC survivors had a significantly higher
thigh and lower leg intermuscular fat to skeletal muscle ratio compared with controls, and this was inversely related
to whole body V̇o2peak. Accordingly, therapies targeted to
reduce intermuscular fat may be an important therapy to
improve V̇o2peak following BC therapy.46
Exercise Prescription and Training
A systematic review and meta-analysis by Scott et al13 found
that exercise training is an effective therapy to increase
V̇o2peak in cancer survivors. The mechanisms responsible
for the exercise training-mediated increase in V̇o2peak in BC
survivors are not well known, however appear to be due to
favorable peripheral (vascular and/or skeletal muscle) adaptations.12 Howden et al,14 using a nonrandomized controlled trial in female patients with early-stage BC, found
that exercise training during anthracycline chemotherapy
attenuated the decline in both V̇o2peak and estimated arterial venous oxygen difference when compared to usual care,
with no significant difference observed between groups for
change in peak HR, stroke volume, or cardiac output. Finally, Mijwel et al15 compared the effects of 16 wk of moderate-intensity aerobic training combined with high-intensity interval training (aerobic training-HIIT) and resistance
training combined with HIIT (resistance training-HIIT)
versus usual care on skeletal muscle morphology and function in female patients with BC undergoing chemotherapy.
A main finding was that both aerobic training-HIIT and
resistance training-HIIT counteracted the decline in citrate
synthase activity, type I muscle fiber cross-sectional area,
and capillaries/fiber found in the usual care group after
16 wk. Also, the change in cancer-related fatigue was inversely related to the change in citrate synthase activity. In
addition to the improvements in overall V̇o2peak and the central and peripheral factors, which influence CRF, exercise
has been shown to reduce risk of cancer-specific mortality,
improve lean body mass, reduce fatigue and depression, improve sleep, and improve overall quality of life for BC survivors. A summary of the current aerobic, resistance, and
flexibility exercise recommendations,35 which elicit these
benefits for cancer survivors, can be found in Table 5.
SPONTANEOUS CORONARY ARTERY DISSECTION
Spontaneous coronary artery dissection is an infrequent,
but increasingly recognized, event that can lead to acute
coronary syndrome (ACS) including MI or sudden death.47
Dissection of a coronary artery is characterized by the spontaneous formation of an intramural hematoma. When an
intimal tear is present, it can result in the creation of a false
lumen where blood can enter but not exit, leading to the
creation of the hematoma. Pressure-driven expansion of
the false lumen and enlargement of the hematoma can lead
to worsening myocardial ischemia due to compression and
narrowing of the true lumen, causing a reduction of blood
flow in the affected artery.
Physical and emotional stressors are considered triggers
of SCAD. In a cohort of 327 patients who suffered SCAD,
62% had a precipitating stressor within 1 wk prior to the
event. Of these 48% were related to an emotional event,
28% to a physical event, and 12% triggered due to heavy
isometric exertion.48
The diagnosis of SCAD is made with coronary angiography and current recommended treatment is conservative,
including the use of β-blockers to reduce intracoronary
shear stress and risk of reoccurrence.47-50 Saw et al48 reported that 83% of those suffering SCAD were initially treat-
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ed conservatively, without stent or coronary artery bypass.
Despite two different scientific statements suggesting optimal management,47,49 there are currently no clinical practice guidelines.
Spontaneous coronary artery dissection occurs most often in young to middle-aged female populations, frequently
at a time of high emotional stress, during intense exercise,
or during childbirth.47,49 It is responsible for up to 35% of
ACS in female patients age ≤50 yr.47 Additionally, there is a
high probability of reoccurrence, leading to related anxiety
and depression.47,51,52 Frequently and paradoxical to most
individuals with ACS and MI, those who suffer SCAD are in
good health, physically fit, and often present with few risk
factors for coronary artery disease.50 Despite this, exercise
training is recommended. However, little information exists
about exercise training in patients with SCAD (Table 3).
Exercise Testing
Published data regarding exercise testing in this population
are sparse. Although not required, testing prior to enrollment in CR may be useful for guiding the exercise prescription, especially in those highly active prior to their SCAD
event. Several studies include completion of a CPX before
and/or after an exercise regimen,47,53-55 but there is no consensus as to protocol; 6MWTs have also been used.54,56 Regardless of the testing method, improvements in functional
capacity in the range of 1.5 metabolic equivalents (METs)
of task have been observed. No adverse events were reported. Standard testing methods are likely appropriate, and the
exercise testing protocol selected will likely be similar to
that used in other patients who experienced ACS or a MI,
including a pre-test assessment of functional capacity.
Exercise Prescription and Training
The American Heart Association recommends that all patients with MI caused by SCAD be referred to CR, and
health care providers overwhelmingly support this,57 yet
referral rates remain low. This is possibly due to provider
fear of reoccurrence (range for rate of recurrence: 0-37%)
or the belief that young, fit patients without coronary artery
disease may not benefit from CR.47 Unfortunately, because
of low referral rates and lack of specific exercise guidelines,
CR staff frequently adopt the methods used with other CR
patients. However, this can be frustrating for those patients
with SCAD because they are often younger and engaged in
higher levels of physical activity prior to their event. Not feeling challenged and/or being treated as if they have coronary
artery disease may lead to low CR participation rates among
patients with SCAD.58,59 A few case reports address an individualized (1:1) or sports-specific approach for SCAD survivors,53,55,60 but currently many CR programs may not have
sufficient staffing or resources to allow for this level of care.
A multidisciplinary CR program in Vancouver, British
Columbia, has published the largest experience of exercise in
patients with SCAD. Exercise was performed 1 d/wk in a dedicated session that included peer support and consisted of 15
min of warm-up, 30 min of aerobic exercise, and 15 min of
cool-down. Resistance training was performed with two 12-lb
free weights and high repetitions. Target HR was set at 5070% of HR reserve based on an entrance exercise treadmill
test. Systolic BP during exercise was limited to <130 mm Hg.
Exercise, HR, and BP thresholds were chosen with the intention of decreasing arterial wall stress and providing a conservative return to activity.61 Outside of formal classes, participants were encouraged to exercise in a supervised gym setting.
In the Vancouver experience, patients were recommended to lift ≤20 lb during daily activities, as some in the
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cohort suffered their SCAD event after lifting more than
20 lb.61 Other published reports have recommended that,
after SCAD, females lift ≤20-30 lb and male patients ≤3050 lb.50,62,63 Because acute, high levels of exercise are associated with SCAD, some have recommended patients avoid
activities performed to exhaustion, any highly competitive
or contact sports, exercise performed in extremes of terrain
or temperature, or activities that involve a Valsalva maneuver such as intense isometric activities.47,53,63,64
There are very limited data on high-intensity exercise in
these patients. Silber et al54 report on nine female patients
who had an MI as the result of SCAD and subsequently
participated in their CR program. Supervised exercise began within 1-2 wk post-event and was prescribed at 6070% HR reserve from an entrance CPX and/or 12-14 on
the 6-20 Borg rating of perceived exertion (RPE) scale.
High-intensity interval training was performed after patients were able to exercise 20 continuous min at their prescribed intensity. One to two-min intervals at RPE 15-17
were interspersed with moderate-intensity intervals of RPE
12-14. Functional capacity increased by 18% (4.4 mL/kg/
min) after completion of five 39 CR visits and no adverse
events were reported.54
LEFT VENTRICULAR ASSIST DEVICES
Left ventricular assist devices (LVADs) continue to be used
increasingly as a therapeutic option for patients with endstage heart failure (HF). Improvements in LVAD technology
have led to better survival. For example, the 2-yr survival
rate for the HeartMate III LVAD (Abbott Cardiovascular),
a fully magnetically levitated centrifugal continuous-flow
pump, is 82.8%, compared with 76.2% for the older HeartMate II (Abbott Cardiovascular), a mechanical-bearing axial continuous-flow pump.65 These advancements have resulted in a nearly six-fold increase in the number of LVAD
recipients over the past decade.66,67 However, despite improvements in both LVAD technology and outcomes, many
patients on LVAD support have poor exercise capacity, especially compared with similar patients who received a heart
transplant.68
Exercise training in this population has shown to be
beneficial for both improvements in exercise capacity and
patient-reported health outcomes (Table 4).68-75 However,
despite this, and despite the fact that the Centers for Medicare & Medicaid Services now covers CR in patients on
LVAD support under HF, only 42% of eligible patients in
this population utilize CR.76
Exercise Testing
While not widely utilized, performing a CPX on patients
with LVAD support can be useful for guiding exercise prescription, risk stratification, and evaluation of native left
ventricle recovery.77,78 Imamura et al77 reported that patients on LVAD support with a V̇o2peak >14 mL∙kg−1∙min−1
had significantly lower 2-yr hospital readmission rate. More
recently, the use of CPX testing has shown potential to help
decide whether selected patients on LVAD support have recovered substantial native function.78 Specifically, the preservation of V̇o2peak following serial CPX testing with full
and minimal LVAD support (ie, LVAD speed is reduced) can
show whether a patient might be a candidate for LVAD explanation (the so-called bridge to recovery).78
Two unique challenges to performing a CPX on these
individuals are obtaining an accurate exercise BP and
managing the LVAD equipment. Due to the nature of current second-generation LVAD models (eg, HeartMate II,

 eartWare), which operate as continuous flow pumps,
H
there is no detectable pulse, which makes both manual and
automatic BP unreliable.79 Therefore, it is recommended
that BP be obtained using a Doppler and a sphygmomanometer.79 While the third-generation HeartMate III does
have a built-in artificial pulse, the use of a Doppler remains
recommended at this time.80
The technique of measuring a Doppler BP is an acquired
skill that takes practice. Therefore, performing periodic
competencies for Doppler measurement is recommended. In
addition, using a stationary cycle for testing is preferred to
help reduce motion artifact when attempting a Doppler BP
during exercise. Another consideration when choosing an
exercise modality is the additional weight of the LVAD batteries and controllers, which may affect the patient balance
with treadmill walking. Assessment of gait and balance
should be done before determining an exercise modality. It
is also important to be aware of the external driveline and
battery lines, which supply power to the LVAD. Unnecessary exposure of these external lines may increase the risk
of the power being disconnected. To avoid this, covering
external lines with a driveline stabilization belt should be
considered before beginning the test.81
Finally, the 6MWT is an additional exercise test to consider. Due to the low functional capacity in this population,
the 6MWT can be used to show a training response from
CR. Importantly, it has also been shown to be an independent prognostic predictor of survival with patients who
achieved <300 m having an increased risk for mortality.82
Exercise Prescription and Training
The LVAD device itself is set at a fixed therapeutic speed
(eg, typical speed of the HeartMate III is 5400 RPM, although this differs between devices) and thus does not
adjust regardless if a person is at rest or exercise. Despite
this, cardiac output can increase from 3-5 to ∼10 L/min.79
Factors, which contribute to this, are increased preload
through the skeletal muscle pump, a reduction in afterload,
which decreases the differential pressure between the LVAD
device and the aorta, thus allowing greater pump flow and
increased contribution by the native left ventricle to move
blood through the aorta (independent of the LVAD).
Despite the presence of a foreign device augmenting cardiac output, the relationship between HR and V̇o2 remains
intact.83 An exception to this would be in patients who
display chronotropic incompetence or are paced with inadequate HR responsiveness.83 For these patients prescribing exercise at a RPE level of 11-14 on the Borg 6-20 scale
would be appropriate. For patients on LVAD support who
do have an intact HR response, a target HR range set at
40-80% HR reserve can be used.35
In this population, HIIT has shown promise with some
preliminary data.73,84 However, more research is needed on
the safety of HIIT in this population and should only be
considered in select patients, based upon factors such as
age, balance, and overall functional abilities.
Muscular strength is an important fitness component
related to patient-reported quality of life as well as length
of hospital stay following LVAD implantation.85,86 The few
training studies that incorporated strength training showed
favorable improvements in strength, and as a result, strength
training should be incorporated as part of a comprehensive
exercise program. As with other patients with a procedure
requiring a sternotomy, precautions should be taken to limit
upper-body strength training until 8-12 wk post-surgery. In
addition, avoiding excessive trunk flexion (eg, sit-ups) or
contact sports is necessary.
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SUMMARY
The four patient populations discussed in this review have
important clinical considerations that should be supervised
by trained exercise professionals. Despite the uniqueness of
the patient populations, compared with individuals without these health conditions, exercise testing and training
appear to be safe and well tolerated, suggesting these individuals can greatly benefit from services commonly offered
in CR. However, high-quality randomized controlled trials,
multisite clinical trials, and additional in-clinic experience
working with these patients are needed to develop more
specific recommendations and ensure patient safety while
maximizing the effectiveness of individualized exercise
programming. Such research may also lead to the support
necessary for insurance reimbursement for exercise training
programs for patients with CKD or BC, similar to what has
been approved by Medicare for individuals with symptomatic peripheral artery disease. It is worth noting that other
clinical populations, such as individuals who have suffered
a stroke, may also benefit from CR services. Recent studies have addressed the need for inclusion of this population
in CR as well as benefits and barriers to participation.87,88
To conclude, understanding these comorbid conditions
that are seen in CR is important to be able to provide safe
and effective therapy for these patients. As summarized in
Tables 2, 3, and 4, current evidence suggests that each of
these populations could experience physical and mental
benefits from regular exercise participation including but
not limited to increased CRF, maximal MET level during a
graded treadmill test, 6MWT duration, muscular strength
as well as improvements to depression symptoms, left ventricular end-diastolic volume, and oxygen uptake at ventilatory threshold. Thus, it is important to consider the inclusion of new populations to CR programs as well as better
understand those who are less commonly seen in CR to help
all patient populations maximize health outcomes and better manage their chronic disease(s).
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